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Abstract
Ciclopirox olamine (CPO), a fungicidal agent widely used in clinical practice,
induced in Saccharomyces cerevisiae an active cell death (ACD) process character-
ized by changes in nuclear morphology and chromatin condensation associated
with the appearance of a population in the sub-G0/G1 cell cycle phase and an arrest
in the G2/M phases. This ACD was associated neither with intracellular reactive
oxygen species (ROS) signaling, as revealed by the use of different classes of ROS
scavengers, nor with a terminal deoxynucleotidyl transferase-mediated dUTP nick
end labeling (TUNEL)-positive phenotype. Furthermore, CPO-induced cell death
seems to be dependent on unknown protease activity but independent of the
apoptotic regulators Aif1p and Yca1p and of autophagic pathways involving
Apg5p, Apg8p and Uth1p. Our results show that CPO triggers in S. cerevisiae an
atypical nonapoptotic, nonautophagic ACD with as yet unknown regulators.
Introduction
Ciclopirox olamine (CPO) belongs to a group of synthetic
antifungal agents, hydroxypyridones, that are used effectively
in clinical practice and that have a very broad spectrum of
action against dermatophytes, yeast, filamentous fungi and
bacteria (Sakurai et al., 1978b; Abrams et al., 1991; Kokjohn
et al., 2003). In addition, this drug has been frequently used
with remarkable success against azole-resistant Candida spe-
cies (Niewerth et al., 2003). Although hydroxypyridones have
been used in clinical practice for the last 30 years, their mode
of action is still poorly understood. Nonetheless, it is well
established that, in contrast to other antifungal agents such as
azoles or polyenes, hydroxypyridones do not produce anti-
fungal activity by inhibition of ergosterol synthesis (Gupta,
2001). CPO is well known as a chelating agent that forms
complexes with iron cations such as Fe31, inhibiting the iron-
containing enzymes, such as catalase and peroxidase, that play
a part in the intracellular degradation of toxic peroxides
(Niewerth et al., 2003). Nevertheless, CPO protects mito-
chondria from hydrogen peroxide toxicity mainly by inhibit-
ing mitochondrial membrane potential depolarization (Lee
et al., 2005b). CPO treatment induces the expression of many
genes involved in iron uptake in Candida albicans cells (Lee
et al., 2005a), which is consistent with CPO acting as an iron
chelator. CPO also inhibits uptake of precursors of macro-
molecule biosynthesis by C. albicans (Sakurai et al., 1978b;
Iwata & Yamaguchi, 1981), but did not affect endogenous
respiration, and therefore interference with electron transport
was not suspected to be the primary cause of its antifungal
activity (Sakurai et al., 1978a). Intracellular CPO is neither
metabolized nor degraded (Sakurai et al., 1978b), with 97%
of the accumulated drug binding irreversibly to the cell
membrane, cell wall, mitochondria and ribosomes, and small
amounts being found free in the cytosol. Transmission
electron microscopy (TEM) studies conducted on CPO-
treated C. albicans cells showed enlargement of the vacuole
and mitochondria, and invagination of the plasma mem-
brane, whereas the cell wall remained unaffected (Niewerth
et al., 2003). It was recently shown that the targets of CPO in
Saccharomyces cerevisiae include many proteins that partici-
pate in different aspects of cellular metabolism, such as DNA
replication, DNA repair, signal transduction, and cellular
transport (Leem et al., 2003).
A significant feature of CPO is that no single case of
fungal resistance has been reported so far, even though it was
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introduced into clinical therapy more than three decades ago.
Niewerth et al. (2003) demonstrated that even the upregula-
tion of well-characterized multidrug resistance genes, e.g.
CDR1, CDR2 and FLU1, or 6 months of exposure to the drug
could not generate CPO resistance in C. albicans. Our knowl-
edge of the fungal targets of this clinically established and very
efficient drug, which has very few side effects when used
topically, is poor (Gupta, 2001). Because of its genetic
tractability and easy laboratory handling, we used S. cerevisiae
as a model to evaluate the mechanisms of the antifungal
action of CPO. In particular, we aimed to determine whether
CPO triggers an active cell death (ACD) pathway, as recently
shown for C. albicans cells treated with amphotericin B
(Phillips et al., 2003). For this purpose, we evaluated CPO
effects on several cellular parameters, such as mitochondrial
function/integrity, plasma membrane integrity, cell cycle
progression, reactive oxygen species (ROS) production,
nuclear morphology, DNA fragmentation, autophagy and
caspase-like or aspartic protease (ASPase) activity.
Materials and methods
Microorganisms and growth conditions
The yeast S. cerevisiae strain BY4742 (MATDhis3D1 leu2D0
lys2D0 ura3D0), susceptible to CPO concentrations higher
than 16mgmL1, and the respective knockouts in YCA1, AIF1,
APG5, APG8 and UTH1 genes were used in the experiments.
The growth experiments were performed in liquid YEPDQ1
medium in 300-mL flasks containing a 2 : 1 air-to-liquid phase
ratio, and incubated on a mechanical shaker (150 r.p.m.) at
26 1C. Cells were grown to early stationary growth phase
(2.5 OD640nm). For specific experiments, cells were grown
to exponential (0.8 OD640nm) or stationary (3.5 OD640nm)
growth phase. OD was measured in a ‘Sprectronic GENESYS
20’ (Thermo Electron Corporation) spectrophotometer.
Treatments with CPO and inhibition of protein
synthesis
Early stationary-phase cells were harvested and suspended
(106 cellsmL1) in YEPD medium containing 0, 16, 18, 20
and 22mgmL1 CPO (SIGMAC-0415). The treatments were
carried out for 200min at 26 1C with shaking (150 r.p.m.).
The cellular effects of CPO on plasma membrane integrity,
mitochondrial function/integrity and ROS production were
kinetically analyzed (0, 60, 90, 120, 200 and 240min) by flow
cytometry as described hereafter. The inhibition of protein
synthesis was performed by adding cycloheximide (Merck),
100mgmL1 (Ludovico et al., 2001b), to the cell suspensions
at the same time as CPO. Cycloheximide at this concentra-
tion did not affect S. cerevisiae viability after 200min of
incubation. Cell viability was determined by CFU counts
after 2 days of incubation at 26 1C on YEPD agar plates. No
further colonies appeared after that incubation period. The
relative survival percentages were calculated, with 100% of
viability corresponding to 1.11 106 cells.
Flow cytometry assays
Flow cytometry assays were performed on an EPICS XL-MCL
(Beckman-Coulter Corporation, Hialeah, FL) flow cytometer,
equipped with an argon-ion laser emitting a 488-nm beam
at 15mW. The green and red fluorescences were collected
through a 488-nm blocking filter, a 550-nm long-pass
dichroic1 with a 525-nmbandpass1 and a 590-nm long-
pass1 with a 620-nmbandpass1, respectively. Q2Twenty thou-
sand cells per sample were analyzed. The data were evaluated
with the MULTIGRAPH software included in the system II
acquisition software for the EPICS XL/XL-MCL version 1.0.
Cell-sorting assays were performed on a BD FACSAria
Cell Sorting System (BD Biosciences, San Jose, CA), using a
Coherent Sapphire solid-state laser at 488 nm. Separation of
cells was carried out at a medium sheath pressure of 26 p.s.i.
and a frequency of 60 kHz. Data were analyzed using
FACSDIVA software.
Assessment of plasma membrane integrity
Plasma membrane integrity was assessed by flow cytometry
using propidium iodide (PI) (Molecular Probes, Eugene,
OR) vital staining as described elsewhere (de la Fuente et al.,
1992) with minor adaptations. Briefly, PI was added to yeast
cell suspensions (106 cellsmL1) from a working solution
(0.5mg of PI in 10mL of Tris/MgCl2 buffer) to a final
concentration of 6.7 mgmL1 and incubated at 37 1C for
15min. Cells with high red fluorescence were considered to
have plasma membrane disruption.
Assessment of mitochondrial function/integrity
and ROS production
Mitochondrial function/integrity was evaluated by flow
cytometry using the fluorescent dye rhodamine 123
(Rh123) (Molecular Probes, Eugene, OR), as described
elsewhere (Ludovico et al., 2001a). Briefly, cells presenting
green fluorescence levels identical to those presented by
heat-killed cells were considered to have disturbances in
mitochondrial function/integrity.
Cellular ROS productionwas kinetically monitored by flow
cytometry with MitoTracker Red CM-H2XRos (Molecular
Probes) staining, as previously described (Ludovico et al.,
2002). Cells presenting high red fluorescence were considered
to have increased intracellular ROS concentrations.
CPO treatment was carried out in the presence of
different classes of ROS scavengers. Ascorbic acid (10mM),
glutathione (5mM) and acetyl-L-carnitine (0.02 g L1) were
added to the cell suspension before addition of CPO. At
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these concentrations, antioxidants did not affect S. cerevisiae
viability after 200min of incubation (data not shown).
Cell cycle analysis
Cell cycle analysis was performed after treatment with 18
and 20 mgmL1 CPO, as described elsewhere (Fortuna et al.,
2000). Briefly, at the desired time points, cells were har-
vested, washed and fixed with ethanol (70% v/v) for 30min
at 4 1C, and this was followed by sonication, treatment with
RNAse for 1 h at 50 1C in sodium citrate buffer (50mM
sodium citrate, pH 7.5), and subsequent incubation with
proteinase K (0.02mg 107 cells). Cell DNAwas then stained
overnight with SYBR Green 10 000 (Molecular Probes),
diluted 10-fold in Tris-EDTA (pH 8.0), and incubated over-
night at 4 1C. Before cytometric analysis, samples were
diluted 1 : 4 in sodium citrate buffer. Determination of cells
in each phase of the cell cycle was performed offline with
MODFIT LT software (Verity Software House, Topsham, ME).
Assessment of nuclear morphology alterations
and terminal deoxynucleotidyl transferase-
mediated dUTP nick end labeling (TUNEL) assay
Changes in the nuclear morphology of CPO-treated S.
cerevisiae cells were assessed by 4,6-diamino-2-phenyl-in-
dole dihydrochloride (DAPI) staining. CPO-treated cells
were harvested, washed, and resuspended in phosphate-
buffered saline (PBS) with DAPI (0.5mgmL1) for 10min.
Stained cells were washed twice with PBS and visualized by
epifluorescence microscopy with an Olympus BX61 micro-
scope with filter wheels, to control excitation and emission
wavelengths, equipped with a high-resolution Olympus
DP70 digital camera. DNA strand breaks were assessed by a
TUNEL assay with the In situ Cell Death Detection Kit,
Fluorescein (Roche Applied Science, Indianapolis, IN) as
described elsewhere (Ludovico et al., 2001b).
Caspase-like or ASPase activity
Caspase-like or ASPase activity was detected using a
CaspSCREEN Flow Cytometric Analysis Kit (Chemicon).
Cells were incubated with the nonfluorescent substrate D2RQ3
at 37 1C for 45min, and then analyzed by flow cytometry
and epifluorescence microscopy. Micrographs were acquired
in an Olympus BX61 microscope with filter wheels, to
control excitation and emission wavelengths, equipped with
a high-resolution Olympus DP70 digital camera.
TEM analysis and confocal microscopy
Cells from different treatment conditions were washed with
phosphate/magnesium buffer (40mM K2HPO4/KH2PO4,
pH 6.5, 0.5mM MgCl2), suspended in 2.5% (v/v) glutar-
aldehyde in 40mM phosphate/magnesium buffer (pH 6.5),
and fixed overnight at 4 1C. After fixation, the cells were
rinsed twice in 0.1M phosphate/citrate buffer (pH 5.8) and
suspended in this buffer containing 10UmL1 lyticase
(Boehringer Mannheim) for about 90min at 37 1C, to digest
the cell wall. After cell wall digestion of the prefixed yeast
cells, protoplasts were washed and postfixed with 2% (w/v)
osmium tetroxide (2 h), and this was followed by 30min of
incubation with 1% (w/v) aqueous uranyl acetate (Silva
et al., 1987). Dehydration was performed as described by
Byers & Goetsch (1991) for embedding vegetatively grown
yeast cells. After 100% ethanol washes, the samples were
transferred to 100% propylene oxide, and incubated with
50% (v/v) propylene oxide and 50% (v/v) Epon (TAAB
Laboratories) for 30min and with 100% Epon overnight.
Cells were transferred to gelatin capsules with 100% Epon
and incubated at 60 1C for 48 h before cutting thin sections
and staining with uranyl acetate and lead acetate. Micro-
graphs were taken with a Zeiss EM 10C electron microscope.
The images in Fig. 2c Q4were acquired in a confocal
Olympus FLUOVIEW microscope with an Olympus PLAPON
60X/oil objective, with a numerical aperture of 1.42, and
using the Olympus FLUOVIEW advanced software.
Reproducibility of the results
The results presented are mean values and SDs of at least
three independent assays. Statistical analyses were carried
out using independent samples t-tests. A P-value less than
0.05 was assumed to denote a significant difference.
Results and discussion
CPO induces S. cerevisiae ACD
Exposure of S. cerevisiae to CPO resulted in dose-dependent
cell death (Fig. 1a). As reported in other instances of
S. cerevisiae ACD (Madeo et al., 1999; Ludovico et al.,
2001b), CPO-induced cell death was attenuated by coin-
cubation with the protein synthesis inhibitor cycloheximide
(Fig. 1a). In addition, these results were shown to be
independent of cell growth phase: exponential, early sta-
tionary, and stationary (Fig. 1b). Moreover, the addition of
cycloheximide after 20min of CPO treatment still abrogated
cell death, showing that death occurs via a mechanism other
than the inhibition of CPO uptake (data not shown).
The plasma membrane is one of the main targets of many
antifungal agents (Groll et al., 1998; Theis & Stahl, 2004). PI
staining showed alterations in plasma membrane integrity
in 23% and 41% of cells when they were treated with 18 and
20 mgmL1 CPO, respectively, for 200min (Fig. 1c). These
results showed that only the high CPO concentration
induced significant damage to plasma membrane integrity,
as previously reported (Sigle et al., 2005), whereas for
18 mgmL1 CPO, the plasma membrane damage was
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considerably lower in comparison to the observed cell death
(Fig. 1a and c). Nonetheless, alterations at the plasma
membrane functional level were not evaluated, and there-
fore their occurrence could not be completely discounted.
Mitochondria are preferential targets for the majority of
antifungal agents. Azoles are the best example, because in
addition to their action at the plasma membrane, they can
indirectly affect mitochondria (Kontoyiannis & Murray,
2003). Although CPO acts as a chelator of Fe31 (Wanner
et al., 2000; Linden et al., 2003; Niewerth et al., 2003), it
seems to be important in the maintenance of mitochondrial
membrane potential (Lee et al., 2005b). We therefore
assessed yeast mitochondrial function/integrity on the basis
of Rh123 staining (Ludovico et al., 2001a). Our results
showed that approximately the same percentage of PI-
positive cells displayed loss of mitochondrial function/
integrity (Fig. 1d). The results obtained with the study of
plasma and of mitochondrial membrane integrity after
200min of 18 mgmL1 CPO treatment suggested that some
cells were being killed by an active process, and prompted us
to analyze the nuclear morphology and chromatin conden-
sation of yeast cells exposed to CPO. The ultrastructural
analyses performed by TEM together with DAPI staining
showed that CPO induced chromatin condensation and
changes in nuclear morphology, respectively (Fig. 2b).
Moreover, CPO induced the appearance of a subpopulation
displaying a decrease in forward scatter (directly correlated
with cell size) as evaluated by flow cytometry (Fig. 2c). Cell
sorting of this subpopulation showed small cells with
compromised plasma membrane integrity but that main-
tained their genome size, as shown by their cell cycle profile
(Fig. 2c). Moreover, as revealed by CFU counts, these cells
had lost their proliferation capacity (data not shown).
The results described above, namely (1) dependence of
cell death on protein synthesis, (2) maintenance of plasma
membrane integrity and of mitochondrial function/integ-
rity, (3) chromatin condensation, and (4) nuclear morpho-
logic changes observed for the majority of S. cerevisiae cells,
when treated with 18 mgmL1 CPO, fit with a scenario of
an ACD process triggered by CPO. On the other hand
cells treated for 200min with 20mgmL1 CPO already dis-
played a phenotype compatible with necrosis that might
also correspond to the final stages of the ACD process,
as previously described for high concentrations of acetic
acid (Ludovico et al., 2001b) or hydrogen peroxide (Madeo
et al., 1999).
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Fig. 1. CPO treatment of wild-type Saccharo-
myces cerevisiae cells results in cell death inde-
pendent of ROS production with minor
alterations in plasma membrane integrity and
mitochondrial membrane function/integrity. (a)
Effect of cycloheximide on the survival of Sacc-
charomyces cerevisiae cells treated for 200 min
with different CPO concentrations. (b) Survival
rate of exponential-phase, early stationary-
phase and stationary-phase cells with different
CPO concentrations, after 200 min of treatment.
(c) Percentage of cells displaying affected plasma
membrane integrity as assessed by flow cyto-
metric quantification of cells after vital staining
with PI. (d) Percentage of cells presenting mito-
chondrial dysfunction as assessed by flow cyto-
metric quantification of cells with increased
levels of Rh123. (e) Percentage of cells with
increased ROS levels, as assessed by flow cyto-
metry using the fluorescent probe MitoTracker
Red CM-H2XRos. (f) Survival rate of CPO-treated
Saccharomyces cerevisiae cells evaluated in the
absence (control) and presence of different
classes of ROS scavengers. Vertical error bars
representSD.
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CPO-induced cell death is independent of ROS
To further characterize the cell death process triggered by
CPO, several yeast apoptotic regulators were studied. ROS are
known to be crucial mediators of yeast apoptosis, being
associated with the vast majority of apoptotic phenotypes
described so far (reviewed in Madeo et al., 2004). Surpris-
ingly, a kinetic study using CPO concentrations of 18 and
20mgmL1, which induce, respectively, about 50% and 60%
loss of viability (Fig. 1a), revealed that only a very low
percentage of CPO-treated cells displayed high intracellular
ROS concentrations, reaching a value of about 10% for the
highest concentration (20mgmL1) after 200min of treat-
ment (Fig. 1e). These results might be explained by CPO’s
ability to function as an iron chelator (Daudu et al., 2002).
Iron is an essential cofactor for mitochondrial electron
transport enzymes as well as for the Fenton reaction, which
might cooperate to inhibit ROS production. Furthermore,
CPO treatment in the presence of different classes of ROS
scavengers did not enhance cell survival (Fig. 1f). For longer
CPO incubation times (up to 400min), an increase of the
percentage of cells with high ROS levels was detected but was
associated with an increase in cell death that was not
prevented by the presence of different ROS scavengers (data
not shown). Overall, these data strongly support the view that
CPO-induced cell death is independent of ROS signaling.
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Fig. 2. CPO induces nuclear morphologic al-
terations, chromatin condensation and the ap-
pearance of a subpopulation with a decreased
forward scatter and compromised plasma
membrane integrity. TEM and epifluorescence
micrographs (DAPI staining) of (a) untreated and
(b) CPO-treated cells (18 mg mL1, 200 min). N,
nuclei. (C) Confocal micrographs of sorted cells
(from control and R1 subpopulation, displaying
a decrease in forward scatter), double stained
with DAPI and ConAQ5 (incubation with
0.2 mg mL1 ConA, 30 min at room tempera-
ture), displaying compromised plasma mem-
brane integrity but a normal cell cycle profile
[density plot, three-dimensional profile analysis
of forward scatter (FS) log, green fluorescence
(FL1) and percentage of events]. Bar, 5 mm (1 mm
for TEM micrographs).
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The involvement of known S. cerevisiae apoptotic regulators
(reviewed in Ludovico et al., 2005), namely apoptosis-
inducing factor (AIF1) and metacaspase (YCA1), was ana-
lyzed under CPO-induced cell death conditions. As a first
approach, survival after CPO treatment was estimated in
each mutant strain in comparison with the wild-type strain.
The results (Fig. 3a) showed that there were no differences
between the survival percentages obtained for each of the
mutant strains, indicating that the respective proteins do
not have a significant role in the signaling and/or execution
of the CPO-induced cell death process. However, c. 20–25%
of the wild-type cells exposed to 18 mgmL1 CPO were
labeled by the D2R substrate [(Asp)2-rhodamine 110],
which enabled the determination of cells with intracellular
caspase-like or other ASPase activities (Fig. 3c). Nonetheless,
an identical level of D2R labeling was observed in Dyca1 cells
treated with 18 mgmL1 CPO (Fig. 3c), indicating that an
ASPase activity independent of YCA1 was present. More-
over, Z-VAD-FMKwas unable to block the observed ASPase
activity in either wild-type or Dyca1 cells (data not shown),
pointing to the presence of a caspase-like or other protease
that was insensitive to Z-VAD-FMK inhibition, as shown by
others (Va´chova´ & Palkova´, 2005).
The number of cells displaying caspase-like or ASPase
activity is quite similar to the percentage of PI-positive cells
under the same conditions (about 23% for 18 mgmL1
CPO). However, D2R staining was previously described to
be a good alternative for detection of caspase-like or ASPase
activity in living yeast cells (Va´chova´ & Palkova´, 2005).
Accordingly, our results show that D2R and PI stain different
cells (Fig. 3d). Altogether, our findings led us to hypothesize
that other unknown protease(s) could be involved in the
CPO-induced cell death of S. cerevisiae, as recently proposed
in different instances (Herker et al., 2004; Va´chova´
& Palkova´, 2005). Another intriguing deviation from a
typical apoptotic cell death process was the observation
that CPO-treated cells had no TUNEL-positive phenotype
(data not shown).
CPO-induced yeast cell death is not autophagic
In order to obtain new insights into the puzzling cell death
pathway induced by CPO in S. cerevisiae cells, we considered
the possibility of this cell death process being autophagic, as
CPO induces an increase in vacuolization observed by TEM
(Fig. 2b). Both Apg5p and Apg8p are crucial for the
formation of the preautophagosomal structure in yeast cells
(Suzuki et al., 2001), and Uth1p is required for the autopha-
gic degradation of mitochondria (Camougrand et al., 2004).
In this regard, the susceptibilities of the Dapg5, Dapg8 and
Duth1 mutant strains were assessed after CPO treatment.
None of the tested mutant strains was shown to have a
different susceptibility to CPO treatment when compared to
the wild-type strain (Fig. 3b). In addition, blocking autop-
hagy with 3-methyladenine (Seglen & Gordon, 1982) did
not inhibit CPO-induced cell death (data not shown).
Altogether, these results indicate that the autophagic path-
ways analyzed are not involved in CPO-induced cell death.
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Fig. 3. CPO-induced cell death is independent
of Saccharomyces cerevisiae apoptotic regula-
tors and of autophagic pathways but is asso-
ciated with a caspase-like or ASPase activity
independent of YCA1. Relative survival, upon
CPO treatment, of wild-type and respective
knockout cells with different (a) apoptotic and
(b) autophagic regulators. (c) Percentages of
wild-type and Dyca1 cells displaying caspase-
like or ASPase activity, assessed by flow cyto-
metric quantification of cells incubated with
D2R. Filled area (gray), untreated cells stained
with D2R. Open area, CPO-treated cells
(18 mg mL1, 200 min). Vertical error bars repre-
sentSD. (d) Epifluorescence micrographs of
CPO-treated wild-type and Dyca1 cells
(18 mg mL1, 200 min), double stained with D2R
and PI. Bar, 5 mm.
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CPO induces the appearance of a sub-G0/G1
population and G2/M arrest/delay
As a consequence of exposure to diverse cytotoxic agents,
DNA damage can occur, leading to an arrest in the cell cycle
and, ultimately, to cell death. DNA damage checkpoints are
critical for the fate of the cell, allowing DNA damage
detection and repair or, when injury is too extensive, cell
death (Tyson et al., 2002). As the mechanism of DNA repair
was shown to be one of the targets of CPO (Leem et al.,
2003), the effect of CPO on cell cycle progression was
assessed through a flow cytometric determination of DNA
content (Fig. 4a). Leem et al. (2003) previously reported for
another S. cerevisiae strain that CPO treatment induces a
general growth arrest at different points of cell cycle. Our
results showed that CPO treatment induced a statistically
significant arrest/delay in the G2/M phases of the cell cycle
(Fig. 4a and b). In addition, CPO treatment induced the
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Fig. 4. CPO induces the appearance of a sub-
G0/G1 population and G2/M arrest/delay. (a)
KineticQ6 analysis of the percentage of Saccharo-
myces cerevisiae cells in each phase of the cell
cycle. (b) Percentage of untreated (control) and
CPO-treated (18 and 20 mg mL1) Saccharo-
myces cerevisiae cells in each phase of the cell
cycle after 240 min of treatment; P  0.05 vs.
control, t-test, n= 3. (c) Density plot of three-
dimensional profile analysis of forward scatter
(FS log), green fluorescence (FL1) and percen-
tage of events of untreated (control) and CPO-
treated (18 and 20 mg mL1) Saccharomyces
cerevisiae cells after 200 min of treatment. (d)
Left panel: Histogram of logarithmic FL3 (red
fluorescence) of PI-stained cells (treated with
18 mg mL1 CPO, 200 min) displaying PI-nega-
tive cells (gray color) used for cell sorting. Middle
panel: Dot plot of logarithmic forward scatter
(FS log) vs. logarithmic side scatter (SS log) of
CPO-treated (18 mg mL1, 200 min) Saccharo-
myces cerevisiae PI-negative cells. Right panel:
Cell cycle profile of PI-negative CPO-treated
(18 mg mL1, 200 min) cells. (e) Left panel: Cell
cycle profile of CPO-treated (18mg mL1,
200 min) cells, displaying a sub-G0/G1 subpopu-
lation (R2). Middle panel: Dot plot of logarithmic
forward scatter (FS log) vs. logarithmic side
scatter (SS log) of Saccharomyces cerevisiae cells
from the R2 subpopulation. Right panel: Dot
plot of logarithmic forward scatter (FS log) vs.
logarithmic side scatter (SS log) of CPO-treated
(18 mg mL1, 200 min) cells.
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appearance of a subpopulation of cells with a lower DNA
content, described as a sub-G0/G1 peak (Fig. 4c), which was
previously associated with UV-induced yeast apoptosis (Del
Carratore et al., 2002). Interestingly, the percentage of cells
in sub-G0/G1 reaches its highest value for a CPO concentra-
tion of 18 mgmL1. In order to exclude artefacts from the
debris associated with necrotic dying cells, which might
produce values on the histogram with a sub-G0/G1 DNA
content, PI-negative cells were sorted after treatment with
18mgmL1 CPO (Fig. 4d, left panel). Cell cycle analysis of
this population revealed the appearance of c. 20% of cells in
the sub-G0/G1 peak (Fig. 4d, right panel). Moreover, when
the sub-G0/G1 peak was gated and the physical scatter
displayed (Fig. 4e, left panel), it was possible to observe that
the cells with lower DNA content had a normal physical
scatter and did not correspond with either debris or the
observed cells with a lower forward scatter. These results
strongly support the observed nuclear alterations and con-
cur with the main conclusion that an unknown ACD process
is induced by CPO.
CPO triggers an atypical ACD pathway
Altogether, our results show that CPO induces an atypical
ACD process in S. cerevisiae. This process is dependent on
protein synthesis, and is characterized by DNA damage as
reflected by cell cycle analysis and the appearance of a sub-
G0/G1 population, nuclear morphologic alterations, and
chromatin condensation. However, this ACD process does
not display a TUNEL-positive phenotype and is indepen-
dent of the known yeast apoptotic regulators, namely AIF1
and YCA1. The detection of non-necrotic wild-type and
Dyca1 cells labeled by D2R suggests that this ACD process is
mediated by other unknown proteases, as proposed in other
scenarios (Herker et al., 2004; Va´chova´ & Palkova´, 2005).
The specific percentage of cells labeled by D2R substrate is in
agreement with the percentage of sub-G0/G1 cells, reinfor-
cing the idea that about 25% of the cells treated with CPO
(18mgmL1) are dying as a result of an atypical ACD
process. Moreover, CPO-induced yeast cell death was not
associated with ROS signaling, as initially described in other
instances (Cheng et al., 2003; Balzan et al., 2004). Although
further studies need to be performed, the data presented
here highlight the use of CPO for research on the identifica-
tion of novel proteases and pathways involved in yeast ACD.
Additionally, the elucidation of cell death pathways triggered
by antifungal drugs may allow the design of new drugs and
the rational use of those available.
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